APA

Vogelzang E. H., Pouw M. F., Nurmohamed M., Kneepkens E. L., Rispens T., Wolbink G. J. & Krieckaert C. L. M. (20150316). Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs. : Annals of the rheumatic diseases.

Chicago

Vogelzang E H, Pouw M F, Nurmohamed M, Kneepkens E L, Rispens T, Wolbink G J and Krieckaert C L M. 20150316. Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs. : Annals of the rheumatic diseases.

Harvard

Vogelzang E. H., Pouw M. F., Nurmohamed M., Kneepkens E. L., Rispens T., Wolbink G. J. and Krieckaert C. L. M. (20150316). Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs. : Annals of the rheumatic diseases.

MLA

Vogelzang E H, Pouw M F, Nurmohamed M, Kneepkens E L, Rispens T, Wolbink G J and Krieckaert C L M. Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs. : Annals of the rheumatic diseases. 20150316.